We serve Chemical Name:tert-Butyl 3-chloropiperidine-1-carboxylate CAS:885275-01-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:tert-Butyl 3-chloropiperidine-1-carboxylate
CAS.NO:885275-01-4
Synonyms:2-Methyl-2-propanyl 3-chloro-1-piperidinecarboxylate;tert-Butyl 3-chloropiperidine-1-carboxylate;3-Chloro-piperidine-1-carboxylic acid tert-butyl ester;1-Piperidinecarboxylic acid, 3-chloro-, 1,1-dimethylethyl ester;HT907;1-BOC-3-CHLORO-PIPERIDINE
Molecular Formula:C10H18ClNO2
Molecular Weight:219.708
HS Code:2933399090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:289.7±33.0 °C at 760 mmHg
Density:1.1±0.1 g/cm3
Index of Refraction:1.487
PSA:29.54000
Exact Mass:219.102600
LogP:1.92
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 2-Methyl-2-propanyl 3-chloro-1-piperidinecarboxylate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-BOC-3-CHLORO-PIPERIDINE physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,HT907 Use and application,tert-Butyl 3-chloropiperidine-1-carboxylate technical grade,usp/ep/jp grade.
Related News: Additional results from the trial with data on another goal of extending survival is expected in 2020, AstraZeneca said. tert-Butyl 3-chloropiperidine-1-carboxylate manufacturer INSPIRE is a global, multi-center, randomized, controlled study to assess the efficacy and safety of IV rigosertib in higher-risk MDS (HR-MDS) patients who had progressed on, failed to respond to, or relapsed after previous treatment with a hypomethylating agent (HMA) within nine cycles over the course of one year after initiation of HMA treatment. tert-Butyl 3-chloropiperidine-1-carboxylate supplier Two sources familiar with the situation told Reuters that the agency had cleared about 10 million doses. tert-Butyl 3-chloropiperidine-1-carboxylate vendor Without disclosing or confirming the number of vaccine doses, the FDA said in a news release that it had authorized two batches of the vaccine for use, that several other batches were not suitable for use and that others were being evaluated. tert-Butyl 3-chloropiperidine-1-carboxylate factory Two sources familiar with the situation told Reuters that the agency had cleared about 10 million doses.
